Genmab — Juni 2019
-
-
Philippe Moreau on CASSIOPEIA https://www.oncologytube.com/video/daratumumab-phase-3-study-phase-3-randomized-study-of-daratumumab-bortezomib-thalidomide-dexamethasone-d-vtd-vs-vtd-in-transplant-eligible-ndmm/10006339 https://www.oncologytube.com/video/daratumumab-phase-3-study-could-be-a-pivotal-study-in-the-approval-of-daratumumab-in-the-united-states-europe-other-countries/10006340
-
@polle1 my perception is that KOL reactions are more positive as hoped for on Cassiopeia, but also a lot of enthusiasm on SC, with comments ranging from 'paradigm changing' ''Practice changing' 'game changing' 'use is inevitable' to 'when can we get this'
-
Søren Løntoft om Cassiopeia og Priority Review. https://penge.borsen.dk/artikel/1/382409/analytiker_om_hastebehandling_af_genmab-ansoegning_positiv_men_kursneutral_nyhed.html
-
just on some of the comments on investor conferences, Genmab's Upcoming Investor & Other Events:
UBS Global Healthcare Conference, May 20-22
Jefferies Global Healthcare Conference, June 4-6
Goldman Sachs Healthcare Conference, June 11-13
JP Morgan European Healthcare Conference, June 20 -
Mine laks har det fint i dag.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind